The Scientist

» FDA

Most Recent

image: Lazarus Drugs

Lazarus Drugs

By | February 1, 2015

While some drugs sail through development, others suffer setbacks, including FDA rejections, before reaching the market.  

1 Comment

image: Science Setbacks: 2014

Science Setbacks: 2014

By | December 25, 2014

This year in life science was marked by paltry federal funding increases, revelations of sequence contamination, and onerous regulations.

0 Comments

image: Top Science Scandals of 2014

Top Science Scandals of 2014

By | December 25, 2014

The stem cell that never was; post-publication peer review website faces legal trouble; biosecurity breaches at federal labs

4 Comments

image: Push For Data Disclosure

Push For Data Disclosure

By | November 21, 2014

Two federal health agencies released proposed rules that would tighten the requirements for reporting clinical trial results.

0 Comments

image: $300M Boost for BRAIN

$300M Boost for BRAIN

By | September 30, 2014

Mix of public, private, philanthropic, and academic investments will fund additional BRAIN Initiative-related projects.

0 Comments

image: FDA OKs siRNA Ebola Drug

FDA OKs siRNA Ebola Drug

By | September 23, 2014

The US Food and Drug Administration gives the green light to deploy an experimental short interfering RNA treatment against Ebola.

0 Comments

image: FDA to Address Female Sexual Dysfunction

FDA to Address Female Sexual Dysfunction

By | August 15, 2014

The federal agency will convene a two-day workshop in October to discuss the development of drugs to treat the issue.

0 Comments

image: FDA Gets Into the Lab Test Game

FDA Gets Into the Lab Test Game

By | August 4, 2014

So-called laboratory-developed tests will eventually face regulations similar to those that currently govern diagnostic tests or kits that are sold to hospitals.

0 Comments

image: Government Cracks Down on Biosecurity

Government Cracks Down on Biosecurity

By | July 15, 2014

After a string of incidents leading to lab closures and a moratorium on the transfer of select agents, US labs are reassessing safety threats within their own walls.

0 Comments

image: CDC Halts Hazardous Biomaterial Transfers

CDC Halts Hazardous Biomaterial Transfers

By | July 11, 2014

Following recent high-profile safety lapses in government labs, the US Centers for Disease Control and Prevention has placed a moratorium on movement of biological materials from BSL-3 and BSL-4 facilities.

0 Comments

Popular Now

  1. Gut Microbes Linked to Neurodegenerative Disease
  2. Infant Microbiome: Vaginal Delivery Versus C-Section
  3. Top 10 Innovations 2016
    Features Top 10 Innovations 2016

    This year’s list of winners celebrates both large leaps and small (but important) steps in life science technology.

  4. Opinion: WHO’s Silence on Cannabis
Rockland